|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.880 EUR | -0.69% |
|
+20.00% | +2.86% |
| 06-16 | AFYREN Approves Appointment of Giuseppe Abrate to the Board of Directors | CI |
| 04-24 | Afyren Wins EUR3 Million EU Grant for Biorefinery in France | MT |
Company Valuation: AFYREN
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 223.6 | 149.4 | 51.49 | 57.18 | 73.11 | 75.2 | - | - |
| Change | - | -33.18% | -65.54% | 11.05% | 27.85% | 2.86% | - | - |
| Enterprise Value (EV) 1 | 165.2 | 95.63 | 6.619 | 26.85 | 40.22 | 81.95 | 106.8 | 151.2 |
| Change | - | -42.12% | -93.08% | 305.67% | 49.79% | 103.74% | 30.32% | 41.57% |
| P/E | -48.2x | -16.1x | -5.36x | -5.92x | -5.28x | -7.16x | -10x | -9.06x |
| PBR | 2.87x | 2.11x | 0.84x | 1.08x | 1.22x | 2.14x | 2.74x | 7.25x |
| PEG | - | -0x | -1.93x | - | -0.1x | 0.3x | 0.4x | -0.9x |
| Capitalization / Revenue | 73.7x | 43.2x | 15.2x | 20x | 32.2x | 23.9x | 6.74x | 2.15x |
| EV / Revenue | 54.4x | 27.7x | 1.96x | 9.38x | 17.7x | 26x | 9.58x | 4.32x |
| EV / EBITDA | -106x | -20.2x | -1.29x | -5.14x | -6.4x | -9.16x | -15.1x | -168x |
| EV / EBIT | -75.9x | -17.9x | -1.12x | -4.42x | -5.63x | -5.75x | -8.65x | -12.9x |
| EV / FCF | -57x | -25x | -1.18x | -4.6x | -6.95x | -3.17x | -4.3x | -6.02x |
| FCF Yield | -1.76% | -4% | -84.4% | -21.8% | -14.4% | -31.5% | -23.3% | -16.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.18 | -0.36 | -0.37 | -0.37 | -0.53 | -0.405 | -0.29 | -0.32 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.036 | 3.456 | 3.379 | 2.862 | 2.273 | 3.15 | 11.15 | 35 |
| EBITDA 1 | -1.564 | -4.742 | -5.114 | -5.227 | -6.289 | -8.95 | -7.05 | -0.9 |
| EBIT 1 | -2.176 | -5.348 | -5.928 | -6.078 | -7.147 | -14.25 | -12.35 | -11.7 |
| Net income 1 | -3.609 | -9.2 | -9.586 | -9.754 | -14.37 | -16.35 | -11.7 | -12.7 |
| Net Debt 1 | -58.41 | -53.79 | -44.87 | -30.33 | -32.89 | 6.75 | 31.6 | 76 |
| Reference price 2 | 8.680 | 5.800 | 1.985 | 2.190 | 2.800 | 2.900 | 2.900 | 2.900 |
| Nbr of stocks (in thousands) | 25,762 | 25,762 | 25,940 | 26,110 | 26,110 | 26,110 | - | - |
| Announcement Date | 3/24/22 | 3/21/23 | 4/2/24 | 3/27/25 | 3/31/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.16x | 26.18x | -9.21x | - | 87.86M | |
| -3.63x | 7.77x | -13.66x | -.--% | 221M | |
| -7.56x | 1.58x | 16.98x | -.--% | 72.5M | |
| Average | -6.12x | 11.85x | -1.96x | 0% | 127.06M | |
| Weighted average by Cap. | -5.19x | 10.84x | -6.81x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALAFY Stock
- Valuation AFYREN
Select your edition
All financial news and data tailored to specific country editions
